Lexeo Therapeutics, Inc. Common Stock (LXEO) valuation · rev $654.0K
Lexeo Therapeutics, Inc. Common Stock (LXEO) rev $654.0K.
| Metric | Value |
|---|---|
| Market cap | $147.7M |
| Revenue | $654.0K |
| P/S | 225.8 |
LXEO valuation FAQ
What is LXEO's market cap?
Lexeo Therapeutics, Inc. Common Stock (LXEO) market cap is $147.7M on the latest cached fundamentals snapshot.
What is LXEO's latest revenue?
Latest cached Lexeo Therapeutics, Inc. Common Stock (LXEO) revenue was $654.0K. Statements: https://lician.com/financials/lxeo
What is LXEO's price-to-sales ratio?
Lexeo Therapeutics, Inc. Common Stock (LXEO) price-to-sales (P/S) is 225.8, cached market cap $147.7M divided by revenue $654.0K.
How many LXEO valuation scalars are listed on this page?
This page lists 3 cached valuation scalars for Lexeo Therapeutics, Inc. Common Stock (LXEO): Market cap, Revenue, and P/S.
Where is LXEO valuation listed?
Cached valuation multiples for Lexeo Therapeutics, Inc. Common Stock (LXEO) are listed at https://lician.com/valuation/lxeo.
Not investment advice. Cached rows, not a live tape.